Clinical usefulness of long term red cell preservative KL-3R3 (CPDA-1) for predeposited autologous transfusions. Phase 3 study.

Inaba, S., Ohto, H., Shibata, Y., Sakamoto, H., Takahashi, K., Juji, T., & Maeda, Y. (1994). Clinical usefulness of long term red cell preservative KL-3R3 (CPDA-1) for predeposited autologous transfusions. Phase 3 study. Journal of the Japan Society of Blood Transfusion, 40(1), 1–13. https://doi.org/10.3925/jjtc1958.40.1